Search Results - "박영실"

Management of Spontaneous Spinal Epidural Hematoma Developedin Children with Hemophilia by 장한나, 윤회수, 박영실

“…Spinal epidural hematoma (SEH) is a rare neurosurgical emergency in which pressure on the spinal cord leads to acute neurological deficits, and is a rare…”
Get full text

Two Cases of Infant Hemophilia A Patients with Inhibitors by 유동욱, 박지경, 박영실

“…Development of inhibitors is currently one of the most serious complications of hemophilia treatment. Typically, the propensity to develop an inhibitor is…”
Get full text

Efforts by the Republic of China Government to Convert Chinese Communist Prisoners of War during the Korean War by Park, Young-sil

“…The Korean War broke out on June 25, 1950. The armistice talks, which began a year into the Korean War, lasted two years due to the issue of prisoners of war…”
Get full text

A Rare Case of Acquired Hemophilia A in Adolescents and Young Adults by Lee, Min Jeong, Park, Young Shil

“…Acquired hemophilia A (AHA) is a rare bleeding disorder, especially in adolescents and young adults (AYAs) attributable to the development of autoantibodies…”
Get full text

Septic Arthritis and Infective Endocarditis in an Adolescent Hemophilia B Patient with an Inhibitor and a Central Venous Access Device by Kim, Jisu, Park, Young Shil

“…Central venous access devices (CVAD) provide hemophilic patients, particularly children, with prolonged reliable venous access to promote routine factor…”
Get full text

Recombinant von Willebrand Factor for Pediatric Patient with von Willebrand Disease: First Report in Korea by Kim, Seoin, Park, Young Shil

“…von Willebrand disease (VWD) is the most common hereditary bleeding disorder. The treatment of VWD consists mainly of desmopressin and plasma-derived von…”
Get full text

The efficacy of bypassing agents in surgery of hemophilia patients with inhibitors by Ju, Hee Young, Jang, Hye Lim, Park, Young Shil

“…Inhibitory antibodies to factor VIII (FVIII) or IX (FIX) are important issues when managing patients with hemophilia A or B. Advances in bypassing agents such…”
Get full text

단일기관에서 시행한 폰빌레브란트병 환자의 수술 경험 by 박보영, 박영실

“…Background: Von Willebrand disease (VWD) is the most common inherited bleeding disorder. Surgery, even relatively minor procedures, in patients with moderate…”
Get full text

Various Complications after a Vascular Procedure in Patients with Hemophilia by Ha, Yeon Soo, Park, Young Shil

“…Hemophilia, an inherited bleeding disorder, is caused by a deficiency of coagulation factor VIII or IX. Most of patients with hemophilia need vascular…”
Get full text

Nodular Fasciitis of External Auditory Canal by Ahn, Jihyun, Kim, Sunyoung, Park, Youngsil

“…Nodular fasciitis is a pseudosarcomatous reactive process composed of fibroblasts and myofibroblasts, and it is most common in the upper extremities. Nodular…”
Get full text

Sequential therapy with activated prothrombin complex concentrates and recombinant activated factor VII to treat unresponsive bleeding in patients with hemophilia and inhibitors: a single center experience by Han, Myung Hee, Park, Young Shil

“…Currently, the greatest challenge in hemophilia treatment is managing hemophilia patients with inhibitors. The two main bypassing agents that are used to treat…”
Get full text

Subgroup analysis of a phase 2/3 study of rurioctocog alfa pegol in patients with severe hemophilia A: efficacy and safety in previously treated Korean patients by You, Chur Woo, Baek, Hee Jo, Park, Sang Kyu, Park, Young Shil, Shin, Ho-Jin, Engl, Werner, Tangada, Srilatha

“…The efficacy and safety of extended half-life, full-length, pegylated recombinant factor VIII rurioctocog alfa pegol [BAX 855, ADYNOVATE (USA)/ADYNOVI…”
Get full text

Allogeneic hematopoietic stem cell transplantation in congenital hemoglobinopathies with myeloablative conditioning and rabbit anti-thymocyte globulin by Park, Bo-Kyoung, Kim, Hyo-Sup, Kim, Seongkoo, Lee, Jae-Wook, Park, Young Shil, Jang, Pil-Sang, Chung, Nack-Gyun, Jeong, Dae-Chul, Cho, Bin

“…Allogeneic hematopoietic stem cell transplantation (HSCT) is a curative therapy for β-thalassemia major (TM) and sickle cell disease (SCD) in children…”
Get full text

혈우병 약물치료의 최신 지견 by 박영실

“…Hemophilia A (factor VIII deficiency) and Hemophilia B (factor IX deficiency) are the most common and serious congenital coagulation disorders. Accurate…”
Get full text

The Use of Rituximab with Immune Tolerance Induction Therapy for Hemophilia A with Inhibitors by Kim, Chae Young, Lee, Keum Nho, Park, Young Shil

“…Inhibitor development is one of the major adverse events associated with increased morbidity and mortality in patients with congenital hemophilia. Recent…”
Get full text

Immune tolerance induction in patients with severe hemophilia A with inhibitors by Ryu, Ji Eun, Park, Young Shil, Yoo, Ki Young, Lee, Kyoo Duck, Choi, Yong-Mook

“…Inhibitory antibodies to factor VIII (FVIII) are an important complication when managing patients with hemophilia A. Immune tolerance induction (ITI) has been…”
Get full text

Recent trends in the incidence of multiple births and its consequences on perinatal problems in Korea by Choi, Sun Hee, Park, Young Sil, Shim, Kye Shik, Choi, Yong Sung, Chang, Ji Young, Hahn, Won Ho, Bae, Chong-Woo

“…The aim of this study was to survey multiple birth data and to analyze the recent trends of multiple births and its consequences on perinatal problems in Korea…”
Get full text

다기관에서의 국내 폰빌레브란트병 실태에 대한 조사 by 설재희, 김현주, 김순기, 유기영, 심예지, 백희조, 박영실, 최은진, 박상규

“…Background: von Willebrand disease (VWD) is the most common inherited bleeding disorder with a prevalence of up to 1%. However in Korea, only 126 VWD patients…”
Get full text

Multiple births conceived by assisted reproductive technology in Korea by Park, Young Sil, Choi, Sun Hee, Shim, Kye Shik, Chang, Ji Young, Hahn, Won Ho, Choi, Yong Sung, Bae, Chong-Woo

“…The recent trends of multiple births (MBs) conceived by assisted reproductive technology (ART) in Korea were analyzed as well as the relationship with maternal…”
Get full text

중증 혈우병 항체 환자에서 시행한 말초삽입 중심혈관 카테터의 유용성 by 박영실, Park, Youngshil

“…The most effective treatment strategy for patients with hemophilia is replacement therapy with FVIII or FIX concentrates, which usually requires long-term,…”
Get full text